This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Feb. 5, 2013




















 


 Area and Association News

APhA commits $1.5 million to ensure patient access to pharmacists' clinical services
AzPA    Share   Share on FacebookTwitterShare on LinkedinE-mail article
Last weekend, the APhA Board of Trustees made a major commitment to give patients access to pharmacists' clinical services. The board's action followed months of preparatory work and direction from our House of Delegates and led to allocation of $1.5 million towards a multiyear, multifaceted, multimillion-dollar effort to help the profession gain recognition of pharmacists' roles as healthcare providers. APhA is committed to working with pharmacy, patient and other healthcare organizations on this initiative and to that end has several initiatives under way right now. However, we know our financial commitment will not be nearly enough without broad support from within and outside the profession.




NACDS, NCPA urge federal officials to expand pharmacists' role in new healthcare delivery models
NACDS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
As federal officials work to advance the establishment of innovative healthcare delivery systems such as accountable care organizations, the National Association of Chain Drug Stores and the National Community Pharmacists Association are calling for them to take regulatory action to expand the role pharmacists can play in such efforts. More

Pharmacist and Patient-Centered Diabetes Care Certificate Training Program
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Date: April 5
The Pharmacist and Patient-Centered Diabetes Care Certificate Training Program is an innovative and intensive certificate program that focuses on the pharmacist's role in the area of diabetes management. The program, which emphasizes a healthcare team approach, seeks to foster the implementation of pharmaceutical care interventions that will promote disease self-management.
More

Not an AzPA member? Join today
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Not an AzPA member? Join the only statewide association representing all pharmacy professionals in all pharmacy practice settings. With over 1,500 members, we are a leading association of pharmacists spreading the news and events of our industry. More

 Pharmacy Updates


ISMP: Hospitals too often neglect drug safety education
Pharmacy Practice News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Educating pharmacists, nurses and physicians in medication safety and evaluating their knowledge and skills in that area are vital if hospitals want to avoid the errors that seriously harm patients and drive up costs. All too often, however, hospitals with other pressing needs push education and staff competency assessment to the back burner. The result, said Dr. Matthew Grissinger, the director of error reporting programs at the Institute for Safe Medication Practices, in Horsham, Pa., is that they miss opportunities to enhance their patient safety strategies. More

Obama administration revises controversial contraception mandate
HealthDay News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Religious organizations that object to providing birth control coverage under the Affordable Care Act would be allowed to hand that responsibility off to a third party under new rules proposed by the Obama administration. The so-called contraception mandate has already been challenged in court by numerous groups on the grounds that it violates their religious beliefs. Federal health officials said that the new rules are an attempt to address some of those concerns. More

Pharmacy departments innovate to reduce readmissions penalty
American Society of Health-System Pharmacists    Share    Share on FacebookTwitterShare on LinkedinE-mail article
With two-thirds of acute care hospitals hit financially by the Hospital Readmissions Reduction Program, pharmacy departments are trying to ensure that inpatients do not need another hospital stay for at least 30 days. Four hospitals whose pharmacy directors agreed to describe some of their department's efforts each face the prospect of losing $1 million or more in Medicare payments this year, according to public reports. More

Is compounding 'denial coma' over?
Pharmacy Practice News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A handful of states across the country are moving swiftly to shore up their regulatory defenses against the possibility of a new pharmacy compounding disaster similar to the fungal meningitis outbreak that by late January had sickened 693 people in 19 states and killed 45. In Iowa, for example, the Board of Pharmacy issued charges against five out-of-state compounding pharmacies following inspections by National Association of Boards of Pharmacy investigators under a contract with the Iowa board. By year-end, NABP inspectors are expected to visit all 582 nonresident pharmacies licensed by the board. More

Want to be published?
MultiBriefs    Share    Share on FacebookTwitterShare on LinkedinE-mail article
In an effort to enhance the overall content of Pharmacy Flash, we'd like to include peer-written articles in future editions. As a member of the pharmaceutical industry, your knowledge lends itself to unprecedented expertise. And we're hoping you'll share this expertise with your peers through well-written commentary. Because of the digital format, there's no word or graphical limit and our group of talented editors can help with final edits. If you're interested in participating, please contact Colby Horton to discuss logistics and payment. More

 In the News


CDC: More adults need vaccines, and not just for flu
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The flu isn't the only illness adults should be immunized against, U.S. health officials recently said, as a new study found current adult vaccination rates in the country "unacceptably low." The report by the Centers for Disease Control and Prevention concluded that a "substantial increase" in adult vaccinations is needed to prevent diseases including pneumonia, tetanus, diphtheria, hepatitis, shingles and whooping cough. More

Pharmacy managers ready to battle drug companies over generic drugs
Herald-Tribune    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A group representing pharmacy benefit managers says it is ready to take on the major pharmaceutical companies that are pushing legislation in Florida and other states that would restrict the use of some generic drugs known as biosimilars. The issue will be up in the Florida Legislature this spring. More

CDC: Flu still widespread but easing in some states
HealthDay News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Continuing a trend that recently emerged, flu activity remains high across the United States but there are reports that the number of infections may be leveling off in some regions of the country, federal health officials recently reported. More

 Medication Updates


FDA panel votes in favor of olodaterol for COPD
Medscape    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A federal advisory panel has voted 15 to 1 with one abstention to recommend approval of olodaterol, a new medication for treating patients with chronic obstructive pulmonary disease. The Pulmonary-Allergy Drugs Advisory Committee of the Food and Drug Administration voted 15 to 1 with one abstention in three separate votes that the data support the efficacy, safety, and approval of Boehringer Ingelheim's olodaterol, a long-acting beta-agonist, delivered via a metered dose inhaler under the proposed trade name Striverdi Respimat. More

Antisense oligonucleotide approved to treat inherited disorder
American Society of Health-System Pharmacists    Share    Share on FacebookTwitterShare on LinkedinE-mail article
FDA recently approved the marketing of mipomersen sodium injection, or Kynamro, as add-on therapy to lipid-lowering medications and diet for the treatment of homozygous familial hypercholesterolemia. Isis Pharmaceuticals Inc., which developed mipomersen sodium, declared the drug the first systemic antisense medication to reach the market. More

FDA clears drug for urea cycle disorders
Medscape    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Food and Drug Administration recently approved glycerol phenylbutyrate for the chronic management of some urea cycle disorders in patients aged 2 years and older. A UCD is a genetic disorder caused by a mutation that results in a deficiency of 1 of the 6 enzymes in the urea cycle. The deficiency ultimately leads to a buildup of ammonia in the blood, which can be fatal. According to the National Urea Cycle Disorders Foundation, the estimated incidence of UCDs is 1 in 8500 births. More


 

AzPA Pharmacy Flash
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Danielle Wegert, Content Editor, 469.420.2696   
Contribute news

Disclaimer: The AzPA Pharmacy Flash is a weekly roundup of articles of interest to pharmacists and pharmacy professionals. This email may contain an advertisement of AzPA and/or third party products and services. Opinions expressed in these articles do not necessarily reflect the views of AzPA or its advertising partners. The AzPA Pharmacy Flash is compiled by MultiBriefs, a division of MultiView, Inc. Factual errors are the responsibility of the listed publication.

This edition of the AzPA Pharmacy Flash was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Feb. 5, 2013
Jan. 29, 2013
Jan. 22, 2013
Jan. 15, 2013



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063